//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
An independent UK charity finding, funding, facilitating biomedical research into ME and providing better education and awareness of this disease in UK & Europe (charity nr. 1153730) www.investinme.org
UK Charity Invest in ME Research









Loading...
MS incidence and severity increase with latitude "We revealed profound UV effects not only in the skin but also in peripheral blood and, preliminarily, in CSF." rdcu.be/fnbHj
Dr Hans Kluge, WHO Regional Director for Europe, opened #IIMEC18, affirming ME - "ME is a serious, complex, multi-system physical illness, involving neurological, immune, and metabolic dysfunction." Press release: investinme.org/IIMER-PR-202... #mecfs #WHO #InvestInMEresearch #IIMER
Thirteen great crime stories and lots of advice on writing authentic crime fiction. All proceeds donated to a great cause #thirteendeadlyintentions @abbie-editorial.bsky.social @investinmeresearch.bsky.social grab your copy now t.co/yU46B6GEXd
Happy E-book publication day #thirteendeadlyintentions 👏👏🥳 great work by @abbie-editorial.bsky.social and everyone involved in this fabulous charity anthology. All proceeds go to a worthy cause @investinmeresearch.bsky.social
Day 3 | The session continued with talks on cardiovascular and immune phenotyping across fatiguing syndromes, Long COVID measurement gaps, post-infectious disease clinics and research, and clinical approaches to treatment. #BREMC15 #IIMEC18 @investinmeresearch.bsky.social #MECFS #Immunology
Day 3 | Session: Therapeutics and Clinical Trials, chaired by Andrew Wilson. Exploring clinical trial platforms, brain fog treatment, hypoxia-induced mitochondrial stress signalling, wearable data, and data sharing in ME/CFS research. @investinmeresearch.bsky.social #BREMC15 #IIMEC18 #MECFS
Yesterday Professor Martin Warren @vitaminb12lab.bsky.social gave talk at the Norwich Health Innovation Conference on "Rethinking Vitamin B12 Diagnostics" Read more about the Warren group's research on vitamin B12 ➡️ buff.ly/i2xqzjZ
3d
9d
#BRMEC15: GLP-1 RAs - Hype, Hope and Hidden Dangers A rare published presentation from our colloquium - Dr Steve Gardner of PrecisionLife on GLP-1 receptor agonists and what the science means for ME investinme.org/brmec15-stev... #IMECW2026 #MEcfs #research
5d
🦠🎗️ A common #Infection may influence how some #cancer therapies perform, revealing new links between #microbes, #immunity, and treatment outcomes. #Microbiology #PublicHealth #Immunology #Infection #CancerResearch #Microsky via @sciencex.bsky.social
✅ Are you a woman aged between 18 and 45? You may be eligible to take part in our COMPASS-ME study. Participation is voluntary and no financial incentives are provided.
10d
12d
13d
6h
1d
7d
7d
UK Charity Invest in ME Research
UK Charity Invest in ME Research
Gib Consultancy
Gib Consultancy
youngEMERG
youngEMERG
rdcu.be
Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS
Quadram Institute
UK Charity Invest in ME Research
Quadram Institute
Microbes.Info
Are you a woman aged between 18 and 45? You may be eligible to take part in the COMPASS-ME Study. The COMPASS-ME Study is investigating potential microbes and infectious triggers associated with…
buff.ly
The COMPASS-ME Study - Quadram Institute
A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important…
medicalxpress.com
Serious infection risks linked to targeted cancer therapies